Skip to main content
HLH-like syndromes associate with increased risk of death and CD19-negative relapse post-CAR T in pediatric B-ALL.
Pediatric autoimmune hemolytic anemia is associated with a high incidence of underlying immune disorders.
Delayed Recognition and Significant Morbidity in Adults with Non-Transfusion-Dependent Thalassemia.
Real-world safety profile of twice a day deferiprone in patients with thalassemia, sickle cell disease, or other anemias.
Yes, we can omit TBI for ALL!
Clinical implications of RAS mutations in AML: Prognostic significance is based upon involved gene and mutation complexity.
In Utero Hematopoietic Cell Transplantation in Fetuses with Alpha Thalassemia Major: A Phase 1 Clinical Trial.
Cure Sickle Cell Initiative Recommendations on Common Data Elements for Sickle Cell Disease Gene Therapy Trials.
TLR8 gain-of-function: on the highway to the danger zone.
American Society of Hematology 2026 Guidelines for the Diagnosis and Management of Severe Acquired Aplastic Anemia.